Progressive systemic sclerosis (Diffuse scleroderma)

Autor: Silber, W., Gitlin, N.

Publikováno v: South African Medical Journal; Vol 39, No 5 (1965)

No Abstract.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=78975075580c::0978374c7fa30e76e4bc51a682e3123b
https://www.ajol.info/index.php/samj/article/view/182696

The incidence of Australia antigen/antibody in acute and chronic liver disease

Autor: Meyers, O.L., Gowdeswell, I.R.G., Gitlin, N., Keraan, M.

Publikováno v: South African Medical Journal; Vol 45, No 10 (1971); 1164-1166
South African Medical Journal; Vol 45, No 9 (1971)

The Australia (AujSH) antigen was sought in patients with -acute viral hepatitis, chronic hepatitis, cirrhosis and hepatoma of the liver. Thirty per cent of patients with :infectious hepatitis and 50% of patients with serum hepatitis had positive tes

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::9ae7b3aacfc426f2dc48ba9cdae80dcd
https://www.ajol.info/index.php/samj/article/view/171086

The antistreptolysin titre diagnostic index (Aso titre) hepatitis

Autor: Gitlin, N., Dowdeswell, I.R., Meyers, O.L.

Publikováno v: South African Medical Journal; Vol 45, No 9 (1971)

series of patients suffering from hepatitis and jaundice were studied in order to ascertain whether the ASO titre would assist in early diagnosis of these diseases, and whether it would help in the differentiation of the various types of hepatitis.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=78975075580c::9669957af373750f54b2f7f774acc1de
https://www.ajol.info/index.php/samj/article/view/170454

Telaprevir for previously untreated chronic hepatitis C virus infection

Autor: Jacobson I. M., McHutchison J. G., Dusheiko G., Di Bisceglie A. M., Reddy K. R., Bzowej N. H., Marcellin P., Muir A. J., Ferenci P., Flisiak R., George J., Rizzetto M., Shouval D., Sola R., Terg R. A., Yoshida E. M., Adda N., Bengtsson L., Sankoh A. J., Kieffer T. L., George S., Kauffman R. S., Zeuzem S., ADVANCE Study Team: Gadano A., Terg R., Bell S., Cheng W., Crawford D., Dore G., MacDonald G., Roberts S., Gschwantler M., Laferl H., Maieron A., Heathcote J., Kaita K., Myers R., Sherman M., Yoshida E., Barange K., Couzigou P., Pawlotsky J. M., Pol S., Serfaty L., Trépo C., Zarski J. P., Berg T., Buggisch P., Diepolder H., Goeser T., Mauss S., Rasenack J., Schmidt W., Wedemeyer H., Baruch Y., Ben Ari Z., Maor Y., Safadi R., Zuckerman E., Colombo M., Baka Cwierz B., Gladysz A., Janczewska Kazek E., Jablkowski M., Krycka W., Diago M., Esteban Mur R., Sanchez Tapias J., Brown A., Fox R., Afdhal N., Arora S., Bennett M., Bernstein D., Bloomer J., Bochan M., Bonkovsky H., Brady C., Brown R., Bzowej N., Cochran J., Chasen R., Davis G., De Jesus E., Di Bisceglie A., Dienstag J., Dieterich D., Etzkorn K., Everson G., Fried M., Freilich B., Ghalib R., Gitlin N., Godofsky E., Gordon S., Hassanein T., Jacobson I., Javadi F., Jonas M., Kilby A., Kwo P., Lawitz E., Lebovics E., Lee W., Luketic V., Maillard M., Monto A., Morgan T., Min A., Murphy M., Nelson D., Northup P., Nyberg L., Pockros P., Poordad F., Poulos J., Reddy R., Rodriguez Torres M., Satyanarayana R., Schiff E., Schwartz H., Shaikh O., Sheikh M., Sherman K., Smith J., Strohecker J., Sulkowski M., Szabo G., Te H., Terrault N., Tsai N., Vargas H., Vierling J., Wruble L., Younossi Z., Zein N., ANDREONE, PIETRO

A B S T R AC T Background In phase 2 trials, telaprevir, a hepatitis C virus (HCV) genotype 1 protease inhibitor, in combination with peginterferon–ribavirin, as compared with peginterferon–ribavirin alone, has shown improved efficacy, with poten

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::052a883adee96e1a0f587feb78d8287d
http://hdl.handle.net/11585/129215

FRI-448 - Responsiveness of controlled attenuation parameter (CAP) and its correlation with magnetic resonance imaging-proton density fat fraction (MRI-PDFF) in a multi-center clinical trial of subjects with nonalcoholic steatohepatitis (NASH)

Autor: Noureddin, M., Kayali, Z., Harrison, S., Ruane, P., Gitlin, N., Lawitz, E., Bennett, M., Vuppalanchi, R., Freilich, B., Harting, E., Mccolgan, B., Myers, R., Middleton, M., Sirlin, C., Charlton, M., Lai, M., Mantry, P., Loomba, R.

Publikováno v: In Journal of Hepatology April 2018 68 Supplement 1:S564-S564